Organophosphate pesticides, cholinergic function and cognitive performance in advanced age
Related Experiment Video
Updated: Oct 16, 2026

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
1Bowles Center for Alcohol Studies and Department of Psychiatry, University of North Carolina School of Medicine, Chapel Hill 27599-7178, USA. dhover@med.unc.edu
Abstract:
The present communication will address the question of whether older individuals/animals are at greater risk to the cognitive impairment induced by exposure to organophosphates (OPs). There is considerable evidence for a decline in cholinergic indices (choline acetyltransferase, acetylcholinesterase, and muscarinic acetylcholine receptors) with aging. Whether these decreases lead to a greater or smaller response to OPs will depend on the relative rate of change in the specific indices. Some studies have shown that aged animals are more sensitive to cholinergic (muscarinic) agonists, even though the receptors are reduced. These findings suggest that aged individuals may be more sensitive to OPs. There is also much evidence documenting the decline in cognitive function in aged animals, a process which is accentuated in Alzheimer's disease and which has been attributed, in part, to the decline in cholinergic indices. Several studies have reported an improvement in cognitive functioning in aged animals/humans following treatment with acetylcholinesterase inhibitors. Thus, it is possible that the cognitive impairment, which occurs during aging, may be partially counteracted during treatment with certain cholinesterase inhibitors (both OPs and nonOPs). Whether the cognitive impairment reported by younger individuals some time after exposure to OPs would be greater in the elderly cannot be predicted on the basis of the available evidence. However, the findings in an animal model of dietary-induced cholinergic hypofunction developed by Roger Russell and colleagues may shed light on this question.
Related Concept Videos
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Indirect-Acting Cholinergic Agonists: Pharmacokinetics
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they are...
Direct-Acting Cholinergic Agonists: Pharmacokinetics
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
